Androgenic profile and genotoxicity evaluation of testosterone propionate and novel synthesized heterocyclic steroids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 110, Issue 3-5, 2008, Pages 284-294

  Hana, Hanaa Y ^a   Khalil, Wagdy K B ^a   Elmakawy, Aida I ^a   Elmegeed, Gamal A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Chromosomal aberrations; Genotoxicity; Heterocycles; RAPD PCR; Sperm analysis; Testosterone

Indexed keywords

17 BETA ACETOXY 2' AMINO 3' ETHANIMIDOYLTHIENO[4',5' 3,2]ANDROST 4 ENE; 17 BETA ACETOXY 2' IMINO 6' PHENYL 1'H PYRIMIDINO[4',5':3,2]ANDROST 4 ENE; 17 BETA ACETOXY 3' CYANO 2' OXO 6' (4 METHOXYPHENYL) 1'H PYRIDO[4',5':3,2]ANDROST 4 ENE; HETEROCYCLIC STEROID; TESTOSTERONE PROPIONATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFECT; DRUG SYNTHESIS; ENZYME MECHANISM; GENOTOXICITY; GERM CELL; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SEMEN ABNORMALITY; SOMATIC CELL; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY;

ANDROGENS; ANIMALS; CHROMOSOME ABERRATIONS; DNA DAMAGE; DNA FRAGMENTATION; DRUG EVALUATION, PRECLINICAL; HETEROCYCLIC COMPOUNDS; MALE; MICE; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, ANDROGEN; SPERMATOZOA; STEROIDS; TESTIS; TESTOSTERONE PROPIONATE;

ANIMALIA; MUS;

EID: 44949096260     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.11.006     Document Type: Article

References (47)

1. Regelson W.M.D., and Colman C. The Super-Hormone Promise (1996), Simon & Schuster, New York. 0-684-83011-6 pp. 115-152
2. Baker H.W.G. Testicular dysfunction in systematic disease. In: Becker K.L. (Ed). Principles and Practice of Endocrinology and Metabolism. 2nd edition (1995), J.B. Lippincott Co., Philadelphia 1083-1089
3. Hendler M.D., and Sheldon Saul Ph.D. The Doctor's Vitamin and Mineral Encyclopedia 201 (1990), Fireside, New York. 0-671-66784-X pp. 385-387
4. Bhasin S., Storer T., Berman N., Callegari C., Clevenger B., Phillips J., Bunnell T.J., Tricker R., Shirazi A., and Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N. Engl. J. Med. 335 1 (1996) 1-7
5. Gray A., Berlin J.A., McKinley J.B., and Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J. Clin. Epidemiol. 44 (1991) 671-684
6. Simon D., Preziosi P., Barrett-Connor E., et al. The influence of aging on plasma sex hormones in men: the Telecom Study. Am. J. Epidemiol. 135 (1992) 783-791
7. Ho S.M., and Yu M. Selective increase in type II estrogen binding sites in the dysplastic dorsolateral prostates of Noble rats. Cancer Res. 53 (1993) 528-532
8. Ho S.M., and Roy D. Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolaterel prostates of Noble rats. Cancer Lett. 84 (1994) 155-162
9. Ragnotti G., Presta M., Maier J.A.M., Rusnati M., Mazzoleni G., Legati F., Chiesa R., Braga M., and Calovini D. Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. Cancer Lett. 36 (1987) 253-261
10. Penov-Gasi K., Sakac M., Djurendic E., Kovacevic R., and Andric S. Rearrangement of some steroidal α,β-unsaturated pyridine-N-oxides and antiandrogenic activity of obtained compounds. J. Serb. Chem. Soc. 63 (1998) 189-192
11. Sparatore F., Cerri R., Delrio G., and Rastogi R.K. 3,4-Dihydro-1,2,4-benzotriazin-3,3′-spirosteriod derivatives of pharmacological interest. Farmaco [Science] 35 (1980) 725-734
12. Clinton R.O., Manson A.J., Stonner F.W., Beyler A.L., Potts G.O., and Arnold A. Steroidal[3,2-c]pyrazoles. J. Am. Chem. Soc. 81 (1959) 1513-1514
13. Zanati G., and Wolff M.E. Heterocyclic steroids 4: synthesis and androgenic activity of A-ring homosteroids. J. Med. Chem. 15 (1972) 368-369
14. Clinton R.O., Manson A.J., Stonner F.W., Neumann H.C., Christiansen R.G., Clarke R.L., Ackerman J.H., Page D.F., Dean J.W., Dickinson W.B., and Carabateas C. Steroidal[3,2-c]pyrazoles. II. Androstanes, 19-norandrostanes and their saturated analogs. J. Am. Chem. Soc. 83 (1961) 1478-1491
15. Christiansen R.G., Bell M.R., D'Ambra T.E., Mallamo J.P., Herrmann J.L., Ackerman J.H., Opalka C.J., Kullnig R.K., Winneker R.C., Snyder B.W., Batzold F.H., and Schane H.P. Antiandrogenic steroidal sulfonylpyrazoles. J. Med. Chem. 33 (1990) 2094-2100
16. IUPAC, and Joint Commission on Biochemical Nomenclature (JCBN). Definitive rules for nomenclature of steroids. J. Am. Chem. Soc. 82 (1960) 5577-5581
17. IUPAC, and Joint Commission on Biochemical Nomenclature (JCBN). The nomenclature of steroids. Recommendations 1989. Eur. J. Biochem. 186 (1989) 429-458
18. Barton D.H.R. Kekule Symposium "Theoretical Organic Chemistry" (1959), Messrs, Buttor, Worth Scientific Publications, London p. 127
19. Safwat H.M., El-Gamal M.H., Hussein M.M., and Abdullah M.M. Functionalization at ring D of some steroids: aldol condensation of aromatic aldehydes with 3-hydroxyandrostane-17-one. Bull. Fac. Pharm. Cairo Univ. 40 (2002) 47-56
20. Nagelberg S.B., Laue L., Loriaux D.L., Liu L., and Sherins R.J. Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. N. Engl. J. Med. 314 10 (1986) 449-450
21. Monesi V. Autoradiographic study of DNA synthesis and the cell cycle in spermatogonia and spermatocytes of mouse testis using tritiated thymidine. J. Cell Biol. 14 (1962) 1-18
22. Jeong S.H., Kim B.Y., Kang H.G., Ku H.O., and Cho J.H. Effects of butylated hydroxyanisole on the development and functions of reproductive system in rats. Toxicology 208 (2005) 49-62
23. Yosida T.H., and Amano K. Autosomal polymorphism in laboratory bred and wild Norway rats, Rattus norvegius, found in Misima. Chromosoma 16 (1965) 658
24. Brewen G.J., and Preston V.R. Analysis of chromosome aberrations in mammalian cells. Chem. Mutagen. 5 (1987) 127-150
25. Sambrook L., Fritsch E.F., and Manitatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Press, Cold Spring Harbor, NY
26. Luceri C., De Filippo C., Caderni G., Gambacciani L., Salvadori M., Giannini A., and Dolara P. Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis. Carcinogenesis 21 9 (2000) 1753-1756
27. Elmegeed G.A., Wardakhan W.W., and Baiuomy A.R. Synthesis of thiazolyl and thieno cholestane derivatives: a novel class of potent antiinflammatory steroids. Pharmazie 60 (2005) 328-333
28. Matsumoto T., Watanabe M., Mataka S., and Thiemann T. Estrano[17,16-e]pyrimidine-peptide conjugates. Steroids 68 9 (2003) 751-757
29. Yin D., He Y., Perera M.A., Hong S.S., Marhefka C., Stourman N., Kirkovsky L., Miller D.D., and Dalton J.T. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptors. Mol. Pharmacol. 63 (2003) 211-223
30. Glen A.T., Hughes L.R., Morris J.J., and Taylor P.J. Structure-activity relationships among nonsteroidal antiandrogens. In: Lambert R.W. (Ed). Proceeding of the Third Sci-RSC Medicinal Chemistry Symposium (1986), Royal Society of Chemistry, London 345-361
31. T.D. Fahey, Anabolic-androgenic steroids: mechanism of action and effects on performance, in: T.D. Fahey (Ed.), Encyclopedia of Sports Medicine and Science, Internet Society for Sport Science: http://sportsci.org, 1998.
32. Narayana K., Prashanthi N., Nayanatara A., Kumar H.H.C., Abhilash K., and Bairy K.L. Effects of methyl parathion (o,o-dimethyl o-4-nitrophenyl phosphorothioate) on rat sperm morphology and sperm count, but not fertility, are associated with decreased ascorbic acid level in the testis. Mutat. Res. 588 (2005) 28-34
33. Rao K.P.S., and Narayana K. In vivo chromosome damaging effects of an inosine monophosphate dehydrogenase inhibitor: ribavirin in mice. Indian J. Pharmacol. 37 2 (2005) 90-95
34. WHO, Pesticide Residues in Food-1995 Evaluations. Part II. Toxicology. WHO/PCS/96.48, International Programme on Chemical Safety, 1995, World Health Organization, Geneva.
35. Vinggaard A.M., Jacobsen H., Metzdorff S.B., Andersen H.R., and Nellemann C. Antiandrogenic effect in short-term in vivo studies of the fungicide fenarimol. Toxicology 207 (2005) 21-34
36. Marzin D. Trenbolone: application of the Ames test. Recent data. Ann. Rech. Vet. 22 3 (1991) 257-262
37. Welder A.A., Robertson J.W., and Melchert R.B. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. J. Pharmacol. Toxicol. Methods 33 4 (1995) 187-195
38. Tsutsui T., Konine A., Huff J., and Barrett J.C. Effects of testosterone, testosterone propionate, 17beta-trenbolone and progesterone on cell transformation and mutagenesis in Syrian hamster embryo cells. Carcinogenesis 16 (1995) 1329-1333
39. Seraj M.J., Umemoto A., Tanaka M., Kajikawa A., Hamada K., and Monden Y. DNA adduct formation by hormonal steroids in vitro. Mutat. Res. 370 1 (1996) 49-59
40. Richold M. The genotoxicity of trenbolone, a synthetic steroid. Arch. Toxicol. 61 (1988) 249-258
41. Morita T., Asano N., Awogi T., Sasaki Y.F., Sato S., Shimada H., Sutou S., Suzuki T., Wakata A., Sofuni T., and Hayashi M. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B). Mutat. Res. 389 (1997) 3-122
42. Holden H.E., Studwell D., and Majeska J.B. Oxymetholone. I. Evaluation in a comprehensive battery of genetic toxicology and in vitro transformation assays. Toxicol. Pathol. 27 (1999) 501-506
43. Martelli A., Mattioli F., Angiola M., Reimann R., and Brambilla G. Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes. Mutat. Res. 536 1-2 (2003) 69-78
44. Reimann R., Kalweit S., and Lang R. Studies for a genotoxic potential of some endogenous and exogenous sex steroids. II. Communication: examination for the induction of cytogenetic damage using the chromosomal aberration assay on human lymphocytes in vitro and the mouse bone marrow micronucleus test in vivo. Environ. Mol. Mutagen. 28 (1996) 133-144
45. Vicdan A., Vicdan K., Günalp S., Kence A., Akarsu C., Zeki A., and Sözen E. Genetic aspects of human male infertility: the frequency of chromosomal abnormalities and Y chromosome microdeletions in severe male factor infertility. Eur. J. Obstet. Gynecol. Reprod. Biol. 117 1 (2004) 49-54
46. Mudry M.D., Palermo A.M., Merani M.S., and Carballo M.A. Metronidazole-induced alterations in murine spermatozoa morphology. Reprod. Toxicol. 23 2 (2007) 246-252
47. Mossuz P., Cousin F., Castinel A., Chauvet M., Sotto M.F., Polack B., Sotto J.J., and Kolodie L. Effects of two sex steroids (17beta estradiol and testosterone) on proliferation and clonal growth of the human monoblastic leukemia cell line, U937. Leuk. Res. 22 11 (1998) 1063-1072